Quantcast

Tough medicine: Court rules firm may get $100M

Annapolis-based PharmAthene Inc. may be entitled to at least $100 million in damages after the Delaware Supreme Court held that Siga Technologies Inc. acted in bad faith in backing out of a proposed licensing agreement for its smallpox treatment medication to be used in response to a biochemical attack.

Leave a Reply

Your email address will not be published. Required fields are marked *

*